公开(公告)号：US20190277862A1

公开(公告)日：2019-09-12

申请号：US16239817

申请日：2019-01-04

Applicant: AJINOMOTO CO., INC.

Inventor： Takeshi IKEUCHI ,  Nobuhiro KAWAI ,  Yuki YANO ,  Naoko ARASHIDA ,  Rumi NISHIMOTO ,  Kazutaka SHIMBO

IPC: G01N33/68

Abstract: An evaluating method includes an evaluating step of evaluating a state of mild cognitive impairment or Alzheimer's disease for a subject to be evaluated using a concentration value of at least one of α-ABA, Ala, Arg, Asn, Cit, Gln, Glu, Gly, His, Ile, Leu, Lys, Met, Orn, Phe, Pro, Ser, Thr, Trp, Tyr, Val, Cysteine, Taurine, GABA, Hypotaurine, S-Adenosyl homocysteine, Sarcosine, Serotonin, Spermidine, hCit, 3-hKyn, aAiBA, N8-Acetylspermidine, Phosphoserine, bABA, ADMA, and Thioproline in blood of the subject.